Cargando…

Estimating the optimal threshold for a diagnostic biomarker in case of complex biomarker distributions

BACKGROUND: Estimating the optimal threshold (and especially the confidence interval) of a quantitative biomarker to be used as a diagnostic test is essential for medical decision-making. This is often done with simple methods that are not always reliable. More advanced methods work well but only fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Subtil, Fabien, Rabilloud, Muriel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062774/
https://www.ncbi.nlm.nih.gov/pubmed/24927622
http://dx.doi.org/10.1186/1472-6947-14-53
_version_ 1782321687751032832
author Subtil, Fabien
Rabilloud, Muriel
author_facet Subtil, Fabien
Rabilloud, Muriel
author_sort Subtil, Fabien
collection PubMed
description BACKGROUND: Estimating the optimal threshold (and especially the confidence interval) of a quantitative biomarker to be used as a diagnostic test is essential for medical decision-making. This is often done with simple methods that are not always reliable. More advanced methods work well but only for biomarkers with very simple distributions. In fact, biomarker distributions are often complex because of a natural heterogeneity in marker expression and other heterogeneities due to various disease stages, laboratory equipments, etc. Methods are required to estimate a biomarker optimal threshold in case of heterogeneity and complex distributions. METHODS: A previously described Bayesian method developed for normally distributed biomarkers is applied to two flexible distributions; namely, a Student-t and a mixture of Dirichlet processes. Here, numerical studies assess the adequacy of the previous method with both distributions. Two applications are presented: the diagnosis of treatment failure after prostate cancer treated by ultrasound and the early diagnosis of cancers of the upper aerodigestive tract. RESULTS: Bayesian inference provided reliable credible intervals in terms of bias and coverage probability. The two distributions analysed gave meaningful clinical interpretations in both applications. CONCLUSIONS: Reliable methods can be used to estimate a biomarker optimal threshold, even in case of complex distributions.
format Online
Article
Text
id pubmed-4062774
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40627742014-06-27 Estimating the optimal threshold for a diagnostic biomarker in case of complex biomarker distributions Subtil, Fabien Rabilloud, Muriel BMC Med Inform Decis Mak Research Article BACKGROUND: Estimating the optimal threshold (and especially the confidence interval) of a quantitative biomarker to be used as a diagnostic test is essential for medical decision-making. This is often done with simple methods that are not always reliable. More advanced methods work well but only for biomarkers with very simple distributions. In fact, biomarker distributions are often complex because of a natural heterogeneity in marker expression and other heterogeneities due to various disease stages, laboratory equipments, etc. Methods are required to estimate a biomarker optimal threshold in case of heterogeneity and complex distributions. METHODS: A previously described Bayesian method developed for normally distributed biomarkers is applied to two flexible distributions; namely, a Student-t and a mixture of Dirichlet processes. Here, numerical studies assess the adequacy of the previous method with both distributions. Two applications are presented: the diagnosis of treatment failure after prostate cancer treated by ultrasound and the early diagnosis of cancers of the upper aerodigestive tract. RESULTS: Bayesian inference provided reliable credible intervals in terms of bias and coverage probability. The two distributions analysed gave meaningful clinical interpretations in both applications. CONCLUSIONS: Reliable methods can be used to estimate a biomarker optimal threshold, even in case of complex distributions. BioMed Central 2014-06-14 /pmc/articles/PMC4062774/ /pubmed/24927622 http://dx.doi.org/10.1186/1472-6947-14-53 Text en Copyright © 2014 Subtil and Rabilloud; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Research Article
Subtil, Fabien
Rabilloud, Muriel
Estimating the optimal threshold for a diagnostic biomarker in case of complex biomarker distributions
title Estimating the optimal threshold for a diagnostic biomarker in case of complex biomarker distributions
title_full Estimating the optimal threshold for a diagnostic biomarker in case of complex biomarker distributions
title_fullStr Estimating the optimal threshold for a diagnostic biomarker in case of complex biomarker distributions
title_full_unstemmed Estimating the optimal threshold for a diagnostic biomarker in case of complex biomarker distributions
title_short Estimating the optimal threshold for a diagnostic biomarker in case of complex biomarker distributions
title_sort estimating the optimal threshold for a diagnostic biomarker in case of complex biomarker distributions
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062774/
https://www.ncbi.nlm.nih.gov/pubmed/24927622
http://dx.doi.org/10.1186/1472-6947-14-53
work_keys_str_mv AT subtilfabien estimatingtheoptimalthresholdforadiagnosticbiomarkerincaseofcomplexbiomarkerdistributions
AT rabilloudmuriel estimatingtheoptimalthresholdforadiagnosticbiomarkerincaseofcomplexbiomarkerdistributions